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~ Expression Tenas¢ln-C In Human Coronary 
Athefoscl~rotic Plaque 
K W~dl~r, PK ~t~h, M C Fi~h~¢!n ~, J~  Ferre~ter, $ K~gl, BG, Shanti 
Att~rosct,~t~ Fle-~oh C~efP.~, Ow~on ot Car~olo~, U,~A: ' D~v+~on at
An~tc~n~c P~I~ C~r~=$i~l~ M~d~Cal C~nf~t, UCLA ,=~¢h~&l ot
A - t~_ ,  t~(~ An~te.~, CA, USA 
h-~5 ~ i~teat~l  to (:ell rn~at!~_~, 0towth and #l~ptos~i~, To d~2¢rmino 
tlV~ ip~l~ntlal rl~k~ of feea,,~c+n-C i~ the paflt(R~lffy;i~o!ot]~/0t ~theto~a;l~ro~l~, w~ 
Iflv~t~oj~t~l tt~ ~pie.~,~to~ f t~_s¢i~(~ in twenty ~v~n hgm.,.-ln cofot~ry 
ti~ii (j~tiN~n.~liali~j !~n~l ~i~l ra~ ~xprP~-~SlOn atlen~in--C in fibnati~ 
all~l~,gl~;olic lal~qg#{i wtlh ma~n'~l ~ no lil~l In Co~lra~l, ~II pt~qges with 
organf~l flp~:l COrn ~ftOfl~= y Cxpre~e(;I ten~¢in,C, which wa~ preferen- 
tially COP.¢~ntrate¢l ~|O~P,~I th# !iDl4J C(~'e arw;l ~houl~t~r r~on-~ Of the I~aq~e 
In r~plu~ plaqge._~, tcna~n~(~ Io~ahgt~J 5Iron,iv a~o'Jnd tlu~ afea of rup. 
Iure. To I~ebiy I~  eel!~at ~rce  ~l tgn,a,~l~G, the ptaque5 were elaln~cl 
with @ell-speeit~ ntil,,o~',i Tins spatial ~li~ilnbullOn atlOflas¢irl.C correlalC-(l 
well wilh the ~r~Irl~g@~.5+ ITOI 1101 ~m~lh m~5¢le (:ells, 6ugge$ting thal 
rr~croi.~ha~es ]rpr~5$ tonascimC Cel! cultured Slu(IIe5 d(~monstraled thai 
n'.,~rogha~es eq~es~ 7.0 kb ten.ascm.G mRNA and 220 kDa protein, as 
detemmned by Nedh~re blot and immunOpre¢ipda~lon studies. RT-PCR anal- 
ysis at ~rophage RNA show*~l that, urdike Cultured smooth muscle ¢e(15, 
maerophages expressed only I~e small =selorm These results demonstrate 
that the expressmn of lenascin-C in aff~emscferoLc plaques correlates with 
the seveety e! the plaque anti troth the mfdtration at macrophages into the 
plaque. 13~s suggests a rate for ~nascm+C in the progression of the d~s* 
ease_ In addition, these data prov¢le novel intern,alien about the ability ol 
macrophages to express tenason-G, implicating tenascin-C as a potential 
mediator of inflammatory esl~nsas. 
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~ ~  Clinical Trial of Bedside CK-MBImv¢ j lobin Panel a 
for  the Early Diagnosis of Acute My¢, -rdial 
In farct-"on 
P L=u, E. Yu, S. Polsky, I. Wheller. E. Wang, P Cho, Y. Gawad, 
M Iwanochko, P. McLaughltn. AS. Detsky The Toronto Hesp~tat. Umv ot 
Toronto, Canada 
Background: To improve the ability to ~agnose myocardial infarction (MI) 
eadier, we prospectively evaluated lhe diagnostic properties ot a beds)de 
panel evaluating CK-MB and royoglobin (MG) in palients presenting wRh 
chest pain. 
Methods: A total et 368 consecutively recruited pts with suspecled cardiac 
chest pain had serial ECG and blood samples drawn at times 0, 2 and 4 hours 
(hr) post presentation, and the panel was activated with 1501+ L at blood in 18 
minutes and interpreted immediately. The gold standard for the diagnosis was 
MI determined by 2 blinded cardiologists reviewing the entire case history. 
Results: The final diagnosis identified 4D Mrs in this population, and the 
diagnostic panel showed: 
CK 0 hr CK 2 hr MG 0 hr MG 2 hr ECG+ MG 0 hr ECG+ MG 2 hr 
Sons 34% 66% 47% 91% 93% 95% 
Spec 93% 8B°,,t 67% 85% 89% 86% 
LikRat 4.8 5 5 3 6 6.1 0 4 6.a 
NPV 94% 96% 95=0 98% 99% 99% 
(Ser.s = sensitivity; Spec = specihc,ty: l[kRat = hkehhood ratios) 
Follow-up af 3 months shewed that patients with positive ECG & MG had 
relative risk ot 2.78 of developing adverse outcome such as death when 
con hated to those with negative tests as reference. 
Conclusions: In the patients presenting with acute chest pain, the com- 
bination ot panel myogtobin with ECG is excellent for "ruling out = acute MI 
within 2 hours at the bedside. Myoglobin is also extremely sensitive tot the 
early detection of acute myocardial infarction, and has significant prognostic 
power al 3 months follow-up. Thus bedside panel of cardiac markers may 
play a novel and important adjunctive role in the early diagnosis of acute MI. 
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~ Pmdl©llve Valu~l el Bedalcle 1~mponln I Tllelhlg In 
Acute Coronary Syncl~me: Iii a Slng~ 1~,opoffin I 
Teat Sufficient? 
I~U Gol~tm,~nn, C ~ l l¢ .n ,  J, ~.hnol(~r, CW, Harem Un+v~i~Jty 
~kgfgUnct Ci~ulatincJ CarglP_~ tropofiin I (eTnt) i~ ~ l!a_n~v~ ~ocr~rn~_~t 
r~rk~r tot d~toction el myocat~4at cob ~ and h~s ~ ~ffowfl Io t~ 
related to =]dvor~ce ~shOft t~rm l~ro0rt0sts InI~t~nt~ (I~S) wtth ~,¢ut~ ¢0r0~ry 
syrcJton~ lAGS), W~e inve~sl+~ted pmfl~CtIvOly th~ v~IL~ at r~ l  IN~_tdo 
cTn! te~lint} inn -= Tt3 pLs with ~¢uts ¢t~t  p~n b~t wlthogt ST-~levat~o~ io 
tP~, Ck_%"tro4~or~OO~m (ECG) in the em~rg~nW room tar ~hOrt,term ogle_ores, 
~.th.Od~- ~amDIo~, we_t_e t~ken on agl~ission (5,2 z 4,0, f~n~ 1.0=12.0 
h~ after on~l of chest pain) ~nd after ~ 4 hf~ inteP#at. Test fe~ultfl were re. 
Isled to 30~lay8 outcon~ with re rinser to (~--~t h or ~Cute myoear~l infar~;on 
(AMI) 
Re~tJtf~' By the time Of admission n :- 10~ pt~ h~d pOSitive eTnl +01 
flg/ml, aft¢~ a 4 hr~ interval 6~ adclitiona( pt~, wer~ eTnl po~tive. Within a 
30.day f011ow.up n + 34 Cardiac events O¢¢urni~l, which wi~ pr~e~ki~l by 
elevated cTnl in the initial 61~°¢irr~n i n = 19 pts (5~%) and in n = 13 pts 
more (94%) 4 hm after admission (:-6 hrs after onset ot pare). 
Nag pred. value Sen~llMty ~thc l ty  
adrn 4 era adm 4 hrs adm 4 hrs 
clnl 97 9 99 7 55 8 94 r 69 1 84 t 
Conclos~ons: In pts with ACS presenting with acute chest pare but without 
ST.elevation admission cTnl measurements allow reliable risk slratiflcation 
Due to low sensitivity a single result on admission is insufficient, a second 
measurement 6 hrs after onset et chest pain is mandatory tar adequate nsk 
assessment. 
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~6-~ Current In~ospita l  Management l~tlents of WRh 
Non-ST Segment Elevation Myocardial Infarction: 
The National Registry of Myocardial Infarction 
Perspective 
M. Burns, R.C. Becket, N.R. Even/, C. Maynard, P. Frederick, J.M. Gore. 
C. 1.3mbrew. Ft," The NRMI Investigators; University of MasSachusetts 
Medic.a/School. Worcester MA, USA 
Background: A nationwide eflod is undenvay to standardaze the care of 
patmnLs w~th acute MI. The purpose ot Our study was to charactenze the 
current m-hospital management el patients wtth non-ST segment elevation 
(non-ST ?) MI. 
Methods: In NRMI-2. a total of 183,113 patients with non-ST ; MI were 
identified. 
Results: 
TreatmenbProcedure ~%) Italia} 24 h In = 183.113) Discharge (n = 161.651) 
Thrombolybcs 7 e 
r 9 PTCA 4.5 
IV HepaJln 630 
Aspmn 69.3 
Nilrates (IVIPO) 50 6 
/~-Blocker (IV/PO) 386 
Cor, Angiography 38,8 
PTCA (excL 1 • PTCA) 16 0 




Patients classified as high nsk for adverse clinical events (43.1% of total 
population) were managed similady in-hospital 1o those at low nsk 
Conclustons:Although additional study is needed to determine the most 
cost-effective management strategy, our findings indicate that many patients 
with non-ST I' MI currently do not receive even the most tundamental forms 
of therapy. 
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~ Reperfusion in Acute Myocardial Syndrome 
Infarction: A Transient Impairment of the 
Microvasculature Associated With a Larger Infarct 
Size and Sustained LV Dysfunction 
L.J. Feldman, D. Himbert, J+-M. Juliard, H. Benamer, P. Aubry. 
O. Boudvillain, M. Faraggi. P.G, Steg. Cardiology Department. Hdpltal 
Bichat. Pans, France 
Background: Repertusion sy~,drome (RS). defined as a transient exacerba- 
0 
CJ 
D 
^ r~ 
Y 
0 
R 
[(A 
